febuxostat has been researched along with Cardiac Diseases in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Abdel-Gaber, SA; Abdelzaher, WY; El-Sheikh, AA; Gad, AA | 1 |
| Bache, RJ; Chen, Y; Hou, M; Hu, Q; Zhang, J; Zhao, L | 1 |
2 other study(ies) available for febuxostat and Cardiac Diseases
| Article | Year |
|---|---|
Purine versus non-purine xanthine oxidase inhibitors against cyclophosphamide-induced cardiac and bone marrow toxicity in rats.
Topics: Allopurinol; Animals; Bone Marrow; Creatine Kinase, MB Form; Cyclophosphamide; Enzyme Inhibitors; Febuxostat; Gout Suppressants; Heart Diseases; Immunosuppressive Agents; L-Lactate Dehydrogenase; Male; Rats; Rats, Wistar; Xanthine Oxidase | 2020 |
Acute effects of febuxostat, a nonpurine selective inhibitor of xanthine oxidase, in pacing induced heart failure.
Topics: Animals; Blood Pressure; Cardiac Pacing, Artificial; Dogs; Febuxostat; Heart Diseases; Thiazoles; Ventricular Function, Left; Xanthine Oxidase | 2006 |